2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Anticoagulants / therapeutic use
  • Arrhythmias, Cardiac / complications
  • Arrhythmias, Cardiac / therapy
  • Blood Transfusion / methods
  • Cardiac Imaging Techniques / methods
  • Carotid Artery Diseases / complications
  • Carotid Artery Diseases / surgery
  • Chronic Disease
  • Contrast Media / adverse effects
  • Coronary Artery Bypass / methods*
  • Coronary Disease / surgery*
  • Decision Making
  • Diabetic Cardiomyopathies / complications
  • Diabetic Cardiomyopathies / surgery
  • Drug Interactions
  • Fibrinolytic Agents / therapeutic use
  • Graft Rejection / etiology
  • Heart Failure / complications
  • Heart Valve Diseases / complications
  • Heart Valve Diseases / surgery
  • Heart-Assist Devices
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Informed Consent
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / surgery*
  • Myocardial Revascularization / methods*
  • Patient Care Team / organization & administration
  • Patient Education as Topic
  • Percutaneous Coronary Intervention / methods*
  • Peripheral Arterial Disease / complications
  • Peripheral Arterial Disease / surgery
  • Purinergic P2Y Receptor Antagonists / therapeutic use
  • Renal Insufficiency, Chronic / complications
  • Reoperation
  • Risk Assessment / methods
  • Stents
  • Thrombolytic Therapy / methods

Substances

  • Anticoagulants
  • Contrast Media
  • Fibrinolytic Agents
  • Hypoglycemic Agents
  • Purinergic P2Y Receptor Antagonists